clotrimazole has been researched along with Candidiasis, Genital in 229 studies
Excerpt | Relevance | Reference |
---|---|---|
"Topical or vaginal clotrimazole treatment during pregnancy was evaluated in the large population-based control data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-92." | 7.70 | A lower rate of preterm birth after clotrimazole therapy during pregnancy. ( Czeizel, AE; Rockenbauer, M, 1999) |
"The author is describing their own clinical experience with the treatment of vaginal candidosis during pregnancy with the application of a single dose clotrimazole 500 mg (Canesten 1) with only one vaginal globule." | 7.69 | [The treatment of vaginal candidiasis during pregnancy with a single dose of clotrimazole]. ( Dukovski, A, 1996) |
"A single vaginal pessary containing clotrimazole 500 mg (Canesten; Bayer-Miles) was used to treat candidiasis during a prospective, mycologically controlled trial among 46 patients in the second and third trimesters of pregnancy." | 7.67 | Treatment of vaginal candidiasis in pregnancy with a single clotrimazole 500 mg vaginal pessary. ( Lindeque, BG; van Niekerk, WA, 1984) |
" These results indicate that CT-containing vaginal MTG might be further developed for safe, convenient, and effective treatment of vaginal candidasis with reduced dosing interval." | 5.31 | Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. ( Chang, JY; Jang, DD; Kim, CK; Kim, EJ; Kong, HS; Nam, KT; Oh, YK, 2002) |
"Clotrimazole use was not clearly associated with an increase in the total (fetal + birth) prevalence of any congenital abnormality group." | 5.30 | No teratogenic effect after clotrimazole therapy during pregnancy. ( Czeizel, AE; Rockenbauer, M; Tóth, M, 1999) |
"It is suggested that early treatment of Candida infections of the vagina during pregnancy can greatly reduce the incidence of fungal infections in the newborn." | 5.26 | The frequency of Candida infections in pregnancy and their treatment with clotrimazole. ( Frerich, W; Gad, A, 1977) |
"A large, adequately powered, randomized trial of clotrimazole to prevent preterm birth in women with asymptomatic candidiasis is both feasible and warranted." | 5.15 | Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial. ( Kotsiou, G; Morris, JM; Rickard, K; Roberts, CL, 2011) |
"A double-blind study was conducted comparing a 3-day (200 mg once a day for 3 consecutive days) treatment with a 6-day (100 mg once a day for 6 consecutive days) treatment of clotrimazole in patients with vaginal mycoses." | 5.05 | Clinical evaluation of three-day treatment of vaginal mycosis with clotrimazole vaginal tablets. ( Cho, N; Mizuno, S, 1983) |
"Ampicillin and clotrimazole may be effective for the reduction of preterm births due to infectious diseases of pregnant women in general but particularly caused by genital infections." | 3.74 | The use of data set of the Hungarian case-control surveillance of congenital abnormalities for evaluation of birth outcomes beyond birth defects. ( Czeizel, AE; Kazy, Z; Puhó, EH, 2007) |
"Topical or vaginal clotrimazole treatment during pregnancy was evaluated in the large population-based control data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-92." | 3.70 | A lower rate of preterm birth after clotrimazole therapy during pregnancy. ( Czeizel, AE; Rockenbauer, M, 1999) |
"The author is describing their own clinical experience with the treatment of vaginal candidosis during pregnancy with the application of a single dose clotrimazole 500 mg (Canesten 1) with only one vaginal globule." | 3.69 | [The treatment of vaginal candidiasis during pregnancy with a single dose of clotrimazole]. ( Dukovski, A, 1996) |
"A single vaginal pessary containing clotrimazole 500 mg (Canesten; Bayer-Miles) was used to treat candidiasis during a prospective, mycologically controlled trial among 46 patients in the second and third trimesters of pregnancy." | 3.67 | Treatment of vaginal candidiasis in pregnancy with a single clotrimazole 500 mg vaginal pessary. ( Lindeque, BG; van Niekerk, WA, 1984) |
"A self-medication therapy with clotrimazole vaginal tablets, application of two tablets at bedtime on 3 consecutive days, was carried out to find out whether vulvo-vaginal mycoses can be treated more effectively and with fewer drop-outs when treatment is simpler and shorter." | 3.66 | Three-day clotrimazole therapy for vulvo-vaginal mycosis. ( Higashide, K; Kawaguchi, C; Tomoda, Y, 1983) |
"Vulvovaginal candidiasis is the second most common cause of vulvovaginal infections." | 2.94 | The effect of Achillea Millefolium L. on vulvovaginal candidiasis compared with clotrimazole: A randomized controlled trial. ( Bijani, A; Esmaeilzadeh, S; Gorji, N; Memariani, Z; Moeini, R; Zakeri, S, 2020) |
"Context • Vulvovaginal candidiasis is the most common infection of the vulvovagina, which manifests with itching, a burning sensation, and leucorrhea." | 2.82 | The Effects of Ozonated Olive Oil and Clotrimazole Cream for Treatment of Vulvovaginal Candidiasis. ( Akhlaghi, F; Azizi, H; Berenji, F; Rajabi, O; Shakeri, MT; Tara, F; Zand-Kargar, Z, 2016) |
" The adverse events of clotrimazole were mainly local." | 2.82 | The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis. ( Fan, S; Guo, X; Li, T; Liang, Y; Liu, X; Zhou, X; Zhu, Y, 2016) |
"Vulvovaginal candidiasis is known as one of the most common fungal infection among women of reproductive age and considered as an important public health problem." | 2.80 | The Comparison of vaginal cream of mixing yogurt, honey and clotrimazole on symptoms of vaginal candidiasis. ( Darvishi, M; Goodarzi, S; Hamzegardeshi, Z; Jahdi, F; Vahedi, M, 2015) |
"Both bacterial vaginosis and candidiasis are commonly seen in pregnancy, with marked differences in pregnancy outcome." | 2.72 | The effect of treatment for vaginal yeast infection on the prevalence of bacterial vaginosis in early pregnancy. ( Friebe, Z; Pawlaczyk, M; Pawlaczyk, MT; Sowinska-Przepiera, E; Wlosinska, J, 2006) |
"Clotrimazole is a safe and effective treatment." | 2.71 | The importance of diagnostic work-up in the management of candidal vulvovaginitis. A prospective study. ( Ben-Haroush, A; Kaplan, B; Yogev, Y, 2004) |
"Econazole was less acceptable to patients than clotrimazole." | 2.67 | Econazole and clotrimazole in the treatment of vaginal candidiasis: a double blind comparative study. ( Perera, J; Seneviratne, HR, 1994) |
"Fluconazole is a new oral triazole antifungal with good activity against Candida spp." | 2.67 | Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis. ( Christensen, S; Mummaw, N; Stein, GE, 1991) |
"The cumulative recurrence frequency after 6 months intermittent prophylaxis with clotrimazole (30." | 2.67 | Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet. ( Forssman, L; Milsom, I; Roth, AC; Wåhlén, P, 1990) |
"Single-dose treatment of vulvovaginal candidiasis with a 500 mg clotrimazole vaginal tablet was compared to 3-day treatment with two 100 mg vaginal tablets administered daily in 115 patients enrolled in a double-blind trial, 101 of whom were evaluated for efficacy." | 2.66 | Efficacy of single- versus multiple-dose clotrimazole therapy in the management of vulvovaginal candidiasis. ( Guess, E; Lebherz, T; Wolfson, N, 1985) |
"Of 30 women given such treatment, 13 relapsed within three months." | 2.66 | Intermittent local prophylaxis against recurrent vaginal candidosis. ( Bushell, TE; Evans, EG; Meaden, JD; Milne, JD; Warnock, DW, 1988) |
"Butoconazole is a new imidazole, effective as therapy for vulvovaginal candidiasis for women who prefer solid-type vaginal preparations." | 2.66 | Three-day treatment with butoconazole vaginal suppositories for vulvovaginal candidiasis. ( Adamson, GD; Brown, D; Henzl, MR; Standard, JV, 1986) |
"Fenticonazole is an imidazole derivative which possesses a broad spectrum antimycotic activity, including activity against Candida albicans." | 2.66 | Effect of fenticonazole in vaginal candidiasis: a double-blind clinical trial versus clotrimazole. ( Brewster, E; Preti, PM; Ruffmann, R; Studd, J, 1986) |
" Maximum plasma levels of radioactivity were achieved 24 hours after dosing and ranged from 19 to 44 ng/mL and fell to background levels after 96 to 120 hours." | 2.65 | Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis. ( Adamson, DG; Brown, D; Cibley, L; Droegemueller, W; Fleury, F; Henzl, MR; LePage, ME, 1984) |
"The high rate of recurrence of this condition is noted and the need for at least 6 months' follow-up in future trials of candidacides is emphasized." | 2.65 | Vulvovaginal candidiasis: treatment and recurrence. ( Dennerstein, GJ; Langley, R, 1982) |
"Two therapeutic regimens were used to treat vulvovaginal candidiasis with clotrimazole vaginal tablets." | 2.65 | A concentrated therapeutic regimen for vulvovaginal candidiasis. ( Robertson, WH, 1980) |
"The incidences of recurrence/reinfection and treatment failures were comparable in the two groups." | 2.65 | A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use. ( Ford, LC; Goldman, L; Lebherz, TB; Mason, D; Wiesmeier, E, 1983) |
"Because many patients experience recurrences once prophylaxis is discontinued, long-term therapy may be warranted." | 2.41 | Treatment of recurrent vulvovaginal candidiasis. ( Ringdahl, EN, 2000) |
"Various agents are available for the treatment of vulvovaginal candidiasis." | 2.38 | Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens. ( Doering, PL; Santiago, TM, 1990) |
"Clotrimazole has long been used to treat vulvovaginal candidiasis (VVC), yet the antibiotic resistance, adverse effects and recurrences still bring about a great challenge for the clinicians." | 1.91 | Improved treatment of vulvovaginal candidiasis with Clotrimazole plus probiotic Lacidophilin Vaginal Capsules: A prospective, real-world study. ( An, R; Li, H; Zeng, X; Zhang, Y, 2023) |
" Novel intravaginal dosage forms focusing on improving patient acceptability and featuring improved biopharmaceutical properties could be interesting alternatives to available antifungal products." | 1.91 | Chitosan-based sponges containing clotrimazole for the topical management of vulvovaginal candidiasis. ( das Neves, J; de Camargo, ER; Martins, F; Morgado, DL; Sarmento, B, 2023) |
"BG-clotrimazole was added into cream base and was examined for dispensability as well as uniformity of the formulation on the skin." | 1.72 | Evaluation of the anticandidal activity of clotrimazole using Lactobacillus caseie ghosts as biological drug carrier. ( Ansari, M; Ayatollahi, SA; Eslaminejad, T; Hasanpore, M; Moshafi, MH, 2022) |
"Vulvovaginal candidiasis is a vaginal infection caused by the fungal pathogen Candida albicans that, most commonly, affects women of reproductive age." | 1.62 | 3D printed clotrimazole intravaginal ring for the treatment of recurrent vaginal candidiasis. ( Campana, R; Casettari, L; Frangipani, E; Tiboni, M, 2021) |
" Furthermore, no association was found between categories of dosage of vaginal antimycotics and spontaneous abortions." | 1.48 | Vaginal antimycotics and the risk for spontaneous abortions. ( Daniel, S; Koren, G; Levy, A; Lunenfeld, E; Rotem, R, 2018) |
"Adjusted free-survival recurrence was 72." | 1.43 | Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504). ( Espadaler, J; Fernández-Moya, JM; Palacios, S; Prieto, C; Salas, N, 2016) |
"Recurrence is a frequent complaint of patients with vulvovaginal candidiasis (VVC)." | 1.40 | Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study. ( Banco, R; De Leo, R; De Santo, D; De Seta, F; Inglese, S; Maso, GP; Parazzini, F; Restaino, S; Sartore, A; Stabile, G; Tonon, M, 2014) |
" These mice intravaginally received essential oils such as geranium and tea tree singly or in combination with vaginal washing." | 1.35 | Protective activity of geranium oil and its component, geraniol, in combination with vaginal washing against vaginal candidiasis in mice. ( Abe, S; Hisajima, T; Inouye, S; Ishibashi, H; Maruyama, N; Takizawa, T; Yamaguchi, H, 2008) |
"Whereas alone, zeamatin was ineffective, nikkomycin Z was effective only when dosed multiple times per day, and clotrimazole efficacy was variable when administered in experimental vehicles (unlike the complex and undefined commercial preparation), zeamatin enhanced the efficacy of either of the other two drugs when they were given in combination." | 1.31 | Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model. ( Calderon, L; Clemons, KV; Martinez, M; Selitrennikoff, CP; Stevens, DA; Wilson, SJ, 2002) |
" These results indicate that CT-containing vaginal MTG might be further developed for safe, convenient, and effective treatment of vaginal candidasis with reduced dosing interval." | 1.31 | Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. ( Chang, JY; Jang, DD; Kim, CK; Kim, EJ; Kong, HS; Nam, KT; Oh, YK, 2002) |
"Of the 22 women who experienced recurrence, the same strain was responsible for the initial and recurrent episode in 17 women." | 1.31 | An investigation into the pathogenesis of vulvo-vaginal candidosis. ( Ashbee, HR; Barton, RC; El-Din, SS; Evans, EG; Reynolds, MT, 2001) |
"Clotrimazole use was not clearly associated with an increase in the total (fetal + birth) prevalence of any congenital abnormality group." | 1.30 | No teratogenic effect after clotrimazole therapy during pregnancy. ( Czeizel, AE; Rockenbauer, M; Tóth, M, 1999) |
"The use of preventive treatment for fungal infections is cautioned due to the possibility of resistance to treatment." | 1.29 | Fungal infection overview. ( , 1995) |
"Vulvovaginal candidiasis is a monoetiologic disease, but the pathways by which pathogenic expression is attained are sufficiently divergent to constitute a classification schema that influences therapy." | 1.27 | Classification and pathogenesis of vulvovaginal candidiasis. ( Monif, GR, 1985) |
"It is suggested that early treatment of Candida infections of the vagina during pregnancy can greatly reduce the incidence of fungal infections in the newborn." | 1.26 | The frequency of Candida infections in pregnancy and their treatment with clotrimazole. ( Frerich, W; Gad, A, 1977) |
"A 17." | 1.26 | Comparison of miconazole-coated tampons with clotrimazole vaginal tablets in the treatment of vaginal candidosis. ( Balsdon, MJ, 1981) |
"Clotrimazole was administered in the form of 100 mg tablets to patients with vaginal candidiasis, and in the form of a 1% solution to patients with cutaneous candidiasis of the genital and perigenital areas." | 1.26 | Genital candidiasis: topical management with clotrimazole. ( Montes, LF; Myers, RP; Ramer, G; Robertson, WH; Soto, TG, 1976) |
"Oral metronidazole was used for the treatment of trichomoniasis in women in 92% of clinics." | 1.26 | Current approaches to the diagnosis, treatment, and reporting of trichomoniasis and candidosis. ( Adler, MW; O'Connor, BH, 1979) |
"In five cases intrahepatic biliary stasis was diagnosed in the course of a Candida albicans septicaemia." | 1.25 | [Fungal infections after renal transplantation (author's transl)]. ( Deutsch, E; Kopsa, H; Schmidt, P; Thurner, J; Zazgornik, J, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 133 (58.08) | 18.7374 |
1990's | 38 (16.59) | 18.2507 |
2000's | 21 (9.17) | 29.6817 |
2010's | 28 (12.23) | 24.3611 |
2020's | 9 (3.93) | 2.80 |
Authors | Studies |
---|---|
Walker, KA | 1 |
Braemer, AC | 1 |
Hitt, S | 1 |
Jones, RE | 1 |
Matthews, TR | 1 |
Heeres, J | 1 |
Hendrickx, R | 1 |
Van Cutsem, J | 2 |
Eslaminejad, T | 1 |
Moshafi, MH | 1 |
Hasanpore, M | 1 |
Ayatollahi, SA | 1 |
Ansari, M | 1 |
Murina, F | 1 |
Lubrano, C | 1 |
Cappelli, E | 1 |
Campo, M | 1 |
Taraborrelli, S | 1 |
Zeng, X | 1 |
An, R | 1 |
Li, H | 1 |
Zhang, Y | 1 |
Martins, F | 1 |
Morgado, DL | 1 |
Sarmento, B | 2 |
de Camargo, ER | 1 |
das Neves, J | 2 |
Nematpour, N | 1 |
Moradipour, P | 1 |
Zangeneh, MM | 1 |
Arkan, E | 1 |
Abdoli, M | 1 |
Behbood, L | 1 |
Thamkhantho, M | 1 |
Chayachinda, C | 1 |
Zakeri, S | 1 |
Esmaeilzadeh, S | 1 |
Gorji, N | 1 |
Memariani, Z | 1 |
Moeini, R | 1 |
Bijani, A | 1 |
Tiboni, M | 1 |
Campana, R | 1 |
Frangipani, E | 1 |
Casettari, L | 1 |
Facchinatto, WM | 1 |
Galante, J | 1 |
Mesquita, L | 1 |
Silva, DS | 1 |
Martins Dos Santos, D | 1 |
Moraes, TB | 1 |
Campana-Filho, SP | 1 |
Colnago, LA | 1 |
Banaeian, S | 1 |
Sereshti, M | 1 |
Rafieian, M | 1 |
Farahbod, F | 1 |
Kheiri, S | 1 |
Xie, HY | 1 |
Feng, D | 1 |
Wei, DM | 1 |
Mei, L | 1 |
Chen, H | 1 |
Wang, X | 1 |
Fang, F | 1 |
Daniel, S | 1 |
Rotem, R | 1 |
Koren, G | 1 |
Lunenfeld, E | 1 |
Levy, A | 1 |
Saghafi, N | 1 |
Karjalian, M | 1 |
Ghazanfarpour, M | 1 |
Khorsand, I | 1 |
Rakhshandeh, H | 1 |
Mirteimouri, M | 1 |
Babakhanian, M | 1 |
Khadivzadeh, T | 1 |
Najafzadeh, MJ | 1 |
Ghorbani, A | 1 |
Pourali, L | 1 |
Bahman, S | 1 |
Russo, R | 1 |
Superti, F | 1 |
Karadja, E | 1 |
De Seta, F | 2 |
Ahangari, F | 1 |
Farshbaf-Khalili, A | 1 |
Javadzadeh, Y | 1 |
Adibpour, M | 1 |
Sadeghzadeh Oskouei, B | 1 |
Genovese, C | 1 |
Cianci, A | 1 |
Corsello, S | 1 |
Ettore, G | 1 |
Mattana, P | 2 |
Tempera, G | 1 |
Wilson, D | 2 |
Hebecker, B | 1 |
Moyes, DL | 1 |
Miramón, P | 2 |
Jablonowski, N | 2 |
Wisgott, S | 2 |
Allert, S | 1 |
Naglik, JR | 1 |
Hube, B | 2 |
Gupta, NV | 1 |
Natasha, S | 1 |
Getyala, A | 1 |
Bhat, RS | 1 |
Tavassoli, K | 1 |
Santos, SS | 1 |
Lorenzoni, A | 1 |
Pegoraro, NS | 1 |
Denardi, LB | 1 |
Alves, SH | 1 |
Schaffazick, SR | 1 |
Cruz, L | 1 |
Parazzini, F | 1 |
De Leo, R | 1 |
Banco, R | 1 |
Maso, GP | 1 |
De Santo, D | 1 |
Sartore, A | 1 |
Stabile, G | 1 |
Inglese, S | 1 |
Tonon, M | 1 |
Restaino, S | 1 |
Zhu, Y | 2 |
Shan, Y | 1 |
Fan, S | 2 |
Li, J | 1 |
Liu, X | 2 |
Kasper, L | 1 |
Brunke, S | 1 |
Darvishi, M | 1 |
Jahdi, F | 1 |
Hamzegardeshi, Z | 1 |
Goodarzi, S | 1 |
Vahedi, M | 1 |
Zhou, X | 1 |
Li, T | 1 |
Guo, X | 1 |
Liang, Y | 1 |
Diaz, MC | 2 |
Camponovo, R | 1 |
Araya, I | 1 |
Cerda, A | 1 |
Santander, MP | 1 |
Carrillo-Muñoz, AJ | 1 |
Wang, FJ | 1 |
Zhang, D | 1 |
Liu, ZH | 1 |
Wu, WX | 1 |
Bai, HH | 1 |
Dong, HY | 1 |
Palacios, S | 1 |
Espadaler, J | 1 |
Fernández-Moya, JM | 1 |
Prieto, C | 1 |
Salas, N | 1 |
Tara, F | 1 |
Zand-Kargar, Z | 1 |
Rajabi, O | 1 |
Berenji, F | 1 |
Akhlaghi, F | 1 |
Shakeri, MT | 1 |
Azizi, H | 1 |
Tapia, CV | 1 |
Hermosilla, G | 1 |
Fortes, P | 1 |
Alburquenque, C | 1 |
Bucarey, S | 1 |
Salinas, H | 1 |
Rodas, PI | 1 |
Magne, F | 1 |
Romero-Cerecero, O | 1 |
Islas-Garduño, AL | 1 |
Zamilpa, A | 1 |
Tortoriello, J | 1 |
Maruyama, N | 1 |
Takizawa, T | 1 |
Ishibashi, H | 1 |
Hisajima, T | 1 |
Inouye, S | 1 |
Yamaguchi, H | 2 |
Abe, S | 1 |
Bachhav, YG | 1 |
Patravale, VB | 1 |
Roberts, CL | 2 |
Rickard, K | 1 |
Kotsiou, G | 2 |
Morris, JM | 2 |
Rickard, KR | 1 |
Giles, WB | 1 |
Simpson, JM | 1 |
Bowen, JR | 1 |
Davis, JD | 1 |
Harper, AL | 1 |
Trinh, HT | 1 |
Lee, IA | 1 |
Hyun, YJ | 1 |
Kim, DH | 1 |
Ray, A | 1 |
Ray, S | 1 |
George, AT | 1 |
Swaminathan, N | 1 |
Sekhavat, L | 1 |
Tabatabaii, A | 1 |
Tezerjani, FZ | 1 |
Stevens, DA | 1 |
Calderon, L | 1 |
Martinez, M | 1 |
Clemons, KV | 1 |
Wilson, SJ | 1 |
Selitrennikoff, CP | 1 |
Friese, K | 1 |
Neumann, G | 1 |
Siebert, J | 1 |
Mendling, W | 2 |
Krauss, C | 1 |
Fladung, B | 1 |
Ben-Haroush, A | 1 |
Yogev, Y | 1 |
Kaplan, B | 1 |
Svare, J | 1 |
Langhoff-Roos, J | 1 |
Retzer, DR | 1 |
Mårdh, PA | 1 |
Wågström, J | 1 |
Landgren, M | 1 |
Holmén, J | 1 |
Williams, A | 1 |
Cepický, P | 1 |
Malina, J | 1 |
Líbalová, Z | 1 |
Kuzelová, M | 1 |
Pawlaczyk, M | 1 |
Friebe, Z | 1 |
Pawlaczyk, MT | 1 |
Sowinska-Przepiera, E | 1 |
Wlosinska, J | 1 |
Corić, M | 1 |
Barisić, D | 1 |
Lovrić, H | 1 |
Czeizel, AE | 3 |
Puhó, EH | 1 |
Kazy, Z | 1 |
Miller, PI | 1 |
Humphries, M | 1 |
Grassick, K | 1 |
Bingham, JS | 2 |
Wiedey, KD | 1 |
Kompa, HE | 1 |
Franz, H | 1 |
Gabriel, G | 1 |
Thin, RN | 1 |
Lebherz, TB | 3 |
Goldman, L | 1 |
Wiesmeier, E | 1 |
Mason, D | 1 |
Ford, LC | 3 |
Mizuno, S | 1 |
Cho, N | 1 |
Thane, E | 1 |
Nielsen, E | 1 |
Nielsen, HM | 1 |
Springer, B | 1 |
Cohen, L | 3 |
Hughes, D | 2 |
Kriedman, T | 1 |
Droegemueller, W | 1 |
Adamson, DG | 1 |
Brown, D | 3 |
Cibley, L | 1 |
Fleury, F | 2 |
LePage, ME | 1 |
Henzl, MR | 2 |
Freiesleben, H | 1 |
Husstedt, W | 1 |
Higashide, K | 1 |
Kawaguchi, C | 1 |
Tomoda, Y | 1 |
Lindeque, BG | 1 |
van Niekerk, WA | 1 |
Burmucic, R | 1 |
Kowatsch, A | 1 |
Wolfson, N | 4 |
Samuels, B | 2 |
Riley, J | 1 |
Goormans, E | 3 |
Bergstein, NA | 1 |
Loendersloot, EW | 3 |
Branolte, JH | 2 |
Stettendorf, S | 2 |
Benijts, G | 3 |
Vignali, M | 1 |
Kreysing, W | 2 |
Wojcik, J | 1 |
Stozek, K | 1 |
Pawlik, B | 1 |
Felman, YM | 1 |
Nikitas, JA | 1 |
Dennerstein, GJ | 1 |
Langley, R | 1 |
Bagdaszewska-Czabanowska, J | 1 |
Wiehler, E | 1 |
Robertson, WH | 4 |
Wszelaki-Lass, E | 1 |
Kuźmińska, A | 1 |
Krause, U | 3 |
Kanadys, W | 1 |
Walkiewicz, W | 1 |
Drela, M | 1 |
Milsom, I | 4 |
Forssman, L | 4 |
Diernaes, E | 1 |
Hansen, BB | 1 |
Pook, D | 1 |
Quiroz Vázquez, R | 2 |
Guevara Correa, LE | 1 |
Plempel, M | 1 |
Balsdon, MJ | 1 |
Lolis, D | 1 |
Kanellopoulos, N | 1 |
Liappas, I | 1 |
Xyngakis, A | 1 |
Zissis, NP | 1 |
Turanova, EN | 1 |
Mirkhodzhaeva, IR | 1 |
Iashikova, GN | 1 |
Voskresenskaia, GA | 1 |
Pavlova, GV | 2 |
Binder, GL | 1 |
Gardner, HL | 1 |
Wells, J | 1 |
Vignalli, M | 1 |
Spitzbart, H | 1 |
Kleinkopf, V | 1 |
Sobel, JD | 3 |
Brooker, D | 1 |
Stein, GE | 4 |
Thomason, JL | 1 |
Wermeling, DP | 1 |
Bradley, B | 1 |
Weinstein, L | 1 |
Perera, J | 1 |
Seneviratne, HR | 1 |
Fong, IW | 4 |
van Heusden, AM | 1 |
Merkus, HM | 1 |
Euser, R | 1 |
Verhoeff, A | 1 |
Schmitt, C | 2 |
Stein, G | 1 |
Mummaw, N | 4 |
Christensen, S | 2 |
Meriwether, C | 2 |
Baron, JR | 1 |
Kelly, RB | 1 |
Taylor, CA | 1 |
Lipsky, MS | 1 |
López Fiesco, A | 1 |
Ayala Ruíz, A | 1 |
Romo, LM | 1 |
Delgado, MD | 1 |
Zamora, G | 1 |
Bannatyne, RM | 1 |
Wong, P | 1 |
Dukovski, A | 2 |
Kolarov, G | 1 |
Suresh, B | 1 |
Sriram, S | 1 |
Dhanaraj, SA | 1 |
Elango, K | 1 |
Chinnaswamy, K | 1 |
Engelhart, CM | 1 |
van de Vijver, NM | 1 |
Nienhuis, SJ | 1 |
Hasaart, TH | 1 |
Sorensen, KN | 1 |
Wanstrom, AA | 1 |
Allen, SD | 1 |
Takemoto, JY | 1 |
Rockenbauer, M | 2 |
Tóth, M | 1 |
Matthews, P | 1 |
Drew, SV | 1 |
Low, L | 1 |
Dalhoff, KP | 1 |
Hartwell, D | 1 |
Ringdahl, EN | 1 |
Spott, J | 1 |
Sevcíková, A | 1 |
Hájek, J | 1 |
Matýsek, P | 1 |
del Palacio, A | 1 |
Sanz, F | 1 |
Sánchez-Alor, G | 1 |
Garau, M | 1 |
Calvo, MT | 1 |
Boncompte, E | 1 |
Algueró, M | 1 |
Pontes, C | 1 |
Gómez de la Cámara, A | 1 |
Deva, R | 1 |
Ciccoli, R | 1 |
Kock, L | 1 |
Nigam, S | 1 |
El-Din, SS | 1 |
Reynolds, MT | 1 |
Ashbee, HR | 1 |
Barton, RC | 1 |
Evans, EG | 3 |
Vasileva, P | 1 |
Bozhkova, K | 1 |
Chang, JY | 1 |
Oh, YK | 1 |
Kong, HS | 1 |
Kim, EJ | 1 |
Jang, DD | 1 |
Nam, KT | 1 |
Kim, CK | 1 |
Davidson, F | 2 |
Mould, RF | 1 |
Ruiz-Velasco, V | 1 |
Rosas-Arceo, J | 1 |
Mayron, J | 1 |
Franklin, R | 1 |
Fernández del Castillo, C | 1 |
Pérez de Salazar, JL | 1 |
Jesús Díaz Loya, FD | 1 |
Mahoney, JD | 1 |
Girgis, MR | 1 |
Haram, K | 1 |
Digranes, A | 1 |
Delektorskii, VV | 1 |
Iashkova, GN | 1 |
Dmitriev, GA | 1 |
Milne, JD | 3 |
Warnock, DW | 3 |
McRipley, RJ | 1 |
Erhard, PJ | 1 |
Schwind, RA | 1 |
Whitney, RR | 1 |
Emokpare, NA | 1 |
Hantschke, D | 1 |
Zabel, M | 1 |
O'Connor, BH | 1 |
Adler, MW | 1 |
Mikrut, W | 1 |
Argemi, J | 1 |
Valls, A | 1 |
Casanova-Bellido, M | 1 |
Lechuga, JL | 1 |
Botet, F | 1 |
Eliot, BW | 1 |
Howat, RC | 1 |
Mack, AE | 1 |
Trovati, GC | 1 |
Ottaggio, G | 1 |
Frerich, W | 1 |
Gad, A | 1 |
Milne, LJ | 3 |
Alvarez Bravo, A | 1 |
Ortíz Pacheco, H | 1 |
Resch, B | 1 |
Altmayer, P | 1 |
Bártfai, G | 1 |
Kliment, V | 1 |
Stefanovic, J | 1 |
Zajac, J | 1 |
Ditte, L | 1 |
Saumann, A | 1 |
Riedemann, R | 1 |
Parra, M | 1 |
Pinto, ME | 1 |
Gostin, L | 1 |
Carmona, E | 1 |
Bhutani, LK | 1 |
Hingorani, V | 1 |
Mohapatra, LN | 1 |
Holt, RJ | 1 |
Soto, TG | 1 |
Ramer, G | 1 |
Myers, RP | 1 |
Montes, LF | 1 |
Masterton, G | 2 |
Henderson, J | 1 |
Napier, IR | 1 |
Moffet, M | 1 |
Zazgornik, J | 1 |
Schmidt, P | 1 |
Thurner, J | 1 |
Kopsa, H | 1 |
Deutsch, E | 1 |
Yris Sánchez, MF | 1 |
Whizar de Yris, B | 1 |
Hernández Falcón, A | 1 |
Pardini, A | 1 |
Pomponi, B | 1 |
Braito, A | 1 |
Campelli, A | 1 |
Corradi, GN | 1 |
Henderson, JN | 1 |
Napier, I | 1 |
Moffett, M | 1 |
Tobin, JM | 1 |
Loo, P | 1 |
Granger, SE | 1 |
García Rafanell, J | 1 |
Dronda, MA | 1 |
Merlos, M | 1 |
Forn, J | 1 |
Torres, JM | 1 |
Zapatero, MI | 1 |
Basi, N | 1 |
Blake, GJ | 1 |
Cucchiarella, MA | 1 |
Varga, A | 1 |
Lovas, J | 1 |
Baumann, RJ | 1 |
Mayer, GD | 1 |
Fite, LD | 1 |
Gill, LM | 1 |
Harrison, BL | 1 |
Nightingale, SL | 1 |
Boag, FC | 1 |
Houang, ET | 2 |
Westrom, R | 1 |
McCormack, SM | 1 |
Lawrence, AG | 2 |
Llaca Rodríguez, V | 2 |
Carrión Tizcareño, H | 2 |
Arguelles Domenzain, P | 2 |
Bro, F | 1 |
Hiscock, E | 1 |
Wells, MB | 1 |
Colli, E | 1 |
Scatigna, M | 1 |
Roth, AC | 1 |
Wåhlén, P | 1 |
Doering, PL | 1 |
Santiago, TM | 1 |
Studd, JW | 1 |
Dooley, MM | 1 |
Welch, CC | 1 |
Vijayakanthan, K | 1 |
Mowat, JM | 1 |
Wade, A | 1 |
Newell, M | 1 |
Robinson, AJ | 1 |
Wilson, JD | 1 |
Spencer, RS | 1 |
Kinghorn, GR | 2 |
Landers, DV | 1 |
Bushell, TE | 2 |
Meaden, JD | 2 |
Llewellyn, PA | 1 |
Westphal, J | 1 |
Herrera Nava, E | 1 |
Bervera Castañeda, R | 1 |
Escalona, S | 1 |
Gutiérrez, M | 1 |
Zamora López, G | 1 |
Adamson, GD | 2 |
Pavić, N | 1 |
Gschwind, C | 1 |
Petranyi, G | 1 |
Meingassner, JG | 1 |
Mieth, H | 1 |
Verö, T | 1 |
Adám, J | 1 |
Ba, J | 1 |
Grcić, R | 1 |
Stavrić, V | 1 |
Barciulli, F | 1 |
Checcucci, V | 1 |
Fabbiani, M | 1 |
Bianchi, W | 1 |
Standard, JV | 1 |
Kjaeldgaard, A | 1 |
Gurwith, D | 1 |
Gurwith, M | 1 |
Chaisilwattana, P | 1 |
Bhiraleus, P | 1 |
Brewster, E | 1 |
Preti, PM | 1 |
Ruffmann, R | 1 |
Studd, J | 1 |
Hodgson, C | 3 |
Graves, K | 1 |
Floyd, R | 2 |
Takada, M | 1 |
Kubota, T | 1 |
Hogaki, M | 1 |
Okawa, T | 1 |
Uchida, K | 1 |
Szarmach, H | 1 |
Małyszko, E | 1 |
Wroński, A | 1 |
Niczyporuk, W | 1 |
Roszkiewicz, J | 1 |
Weisberg, M | 1 |
Breuker, G | 1 |
Jurczok, F | 1 |
Lenaerts, M | 1 |
Weinhold, E | 1 |
McManus, TJ | 1 |
Bingham, J | 1 |
Grice, G | 1 |
Spencer, RC | 1 |
Steele, CE | 1 |
Wiesenhaan, PE | 1 |
Barthel, PJ | 1 |
Lebherz, T | 1 |
Guess, E | 1 |
Siedentopf, HG | 1 |
Wesel, S | 1 |
Ubachs, JM | 1 |
Dogniez, B | 1 |
Monif, GR | 1 |
Facchini, V | 1 |
Tan, CG | 1 |
Good, CS | 1 |
Loudon, JD | 1 |
Hirsch, HA | 1 |
Dedes, M | 1 |
Marks, HJ | 1 |
Lohmeyer, H | 1 |
Legal, HP | 1 |
Schnell, JD | 1 |
Dunster, GD | 1 |
Widholm, O | 1 |
Cartwright, RY | 1 |
Couchman, JM | 1 |
Higton, BK | 1 |
Oates, JK | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Comparative Study of the Efficacy of 10.0 mg Dequalinium Chloride (Fluomizin®) and 100 mg Clotrimazole (Canesten®) for the Treatment of Vulvovaginal Candidiasis[NCT02242695] | Phase 4 | 150 participants (Actual) | Interventional | 2014-11-30 | Completed | ||
Phase 1 Single-Centre, Double-Blind, Randomized, Placebo-Controlled, Multiple Ascending Dose Clinical Trial to Evaluate the Safety, Tolerability and Acceptability of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Female Volunteers[NCT05587283] | Phase 1 | 24 participants (Anticipated) | Interventional | 2022-11-02 | Recruiting | ||
An Case-controlled Randomized Study to the Efficacy of Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis[NCT02180828] | Phase 4 | 240 participants (Actual) | Interventional | 2014-07-31 | Completed | ||
Interventional Study to Evaluate the Effect of a Food Supplement Comprising L. Plantarum After Oral Intake in Vaginal Microbiota[NCT04461782] | 30 participants (Actual) | Interventional | 2019-04-15 | Completed | |||
A Phase IIa Randomized, Active-controlled, Double-blind, Dose-escalation Study in Patients With Vulvovaginal Candidiasis to Evaluate Dose Response Relationship of Clinical Efficacy, Safety and Tolerability of Topically Administered ProF-001[NCT03115073] | Phase 2/Phase 3 | 84 participants (Actual) | Interventional | 2017-04-04 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Systemic: weak, palpitation, tachycardia, migraine, headache, dizzy, rhinorrhea, numb, dizziness, fatigue. (NCT02180828)
Timeframe: at day 7-14 follow up
Intervention | participants (Number) |
---|---|
Clotrimazole Vaginal Tablet | 1 |
Fluconazole | 9 |
Vulvovaginal pruritus, burning, irritation, and bleeding (NCT02180828)
Timeframe: at day 7-14 follow up
Intervention | participants (Number) |
---|---|
Clotrimazole Vaginal Tablet | 12 |
Fluconazole | 1 |
Gastrointestinal tract: abdominal pain, diarrhoea, nausea (NCT02180828)
Timeframe: at day 7-14 follow up
Intervention | participants (Number) |
---|---|
Clotrimazole Vaginal Tablet | 3 |
Fluconazole | 3 |
Skin sensitivity, urticaria rash, erythematous rash, irritation (NCT02180828)
Timeframe: at day 7-14 follow up
Intervention | participants (Number) |
---|---|
Clotrimazole Vaginal Tablet | 0 |
Fluconazole | 3 |
The clinical cure rates of clotrimazole and fluconazol: Clinical cure was defined as the resolution of symptoms present at baseline with a total severity score of ≤2. Improvement was defined as considerable reduction in the severity of baseline signs and symptoms with a decrease in the total score by ≥50%.Patients not clinically cured or showing improvement were considered clinical failures. (NCT02180828)
Timeframe: 7-14 days after treatment (=visit 2)
Intervention | participants (Number) |
---|---|
Clotrimazole Vaginal Tablet | 102 |
Fluconazole | 98 |
The clinical cure rates of clotrimazole and fluconazol (NCT02180828)
Timeframe: at days 30-35 follow-up
Intervention | participants (Number) |
---|---|
Clotrimazole Vaginal Tablet | 82 |
Fluconazole | 85 |
Mycological cure of clotrimazole group and fluconazole group (NCT02180828)
Timeframe: at days 7-14 follow-up
Intervention | participants (Number) |
---|---|
Clotrimazole Vaginal Tablet | 90 |
Fluconazole | 81 |
Mycological cure of clotrimazole group and fluconazole group: Mycological cure or failure was referred to as Candida negative or positive,respectively, on Candida culture at follow-up visits. (NCT02180828)
Timeframe: at days30-35 follow-up
Intervention | participants (Number) |
---|---|
Clotrimazole Vaginal Tablet | 62 |
Fluconazole | 61 |
Total adverse events(cases) (NCT02180828)
Timeframe: at day 7-14 follow up
Intervention | participants (Number) |
---|---|
Clotrimazole Vaginal Tablet | 16 |
Fluconazole | 12 |
8 reviews available for clotrimazole and Candidiasis, Genital
Article | Year |
---|---|
Probiotics for vulvovaginal candidiasis in non-pregnant women.
Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fl | 2017 |
Combined systemic (fluconazole) and topical (metronidazole + clotrimazole) therapy for a new approach to the treatment and prophylaxis of recurrent candidiasis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrim | 2019 |
Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrima | 2011 |
Selections from current literature: issues in the management of vaginitis.
Topics: Candidiasis, Vulvovaginal; Chronic Disease; Clotrimazole; Female; Humans; Male; Metronidazole; Recur | 1993 |
Recurrent vaginal thrush and soreness.
Topics: Adult; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Dia | 1999 |
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; | 2000 |
Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Costs and Cost Analysis; Female; Humans; | 1990 |
The treatment of vaginitis: Trichomonas, yeast, and bacterial vaginosis.
Topics: Antifungal Agents; Bacterial Infections; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administratio | 1988 |
113 trials available for clotrimazole and Candidiasis, Genital
Article | Year |
---|---|
The role of female intimate hygiene practices in the management of vulvovaginal candidiasis: A randomized, controlled open-label trial.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Hygiene; Pruritus; Thymo | 2023 |
Vaginal tablets of dequalinium chloride 10 mg versus clotrimazole 100 mg for vaginal candidiasis: a double-blind, randomized study.
Topics: Adult; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Deq | 2021 |
The effect of Achillea Millefolium L. on vulvovaginal candidiasis compared with clotrimazole: A randomized controlled trial.
Topics: Achillea; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Double-Blind Method; Fe | 2020 |
Comparison of vaginal ointment of honey and clotrimazole for treatment of vulvovaginal candidiasis: A random clinical trial.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Female; Honey; | 2017 |
The effect of a vaginal suppository formulation of dill (Anethum graveolens) in comparison to clotrimazole vaginal tablet on the treatment of vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Adult; Anethum graveolens; Antifungal Agents; Candidiasis, Vulvovagina | 2018 |
Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment.
Topics: Adolescent; Adult; Animals; Anti-Infective Agents; Candidiasis, Vulvovaginal; Chemoradiotherapy, Adj | 2019 |
Comparing the effectiveness of Salvia officinalis, clotrimazole and their combination on vulvovaginal candidiasis: A randomized, controlled clinical trial.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Double-Blind Method; Drug Therapy | 2019 |
The Comparison of vaginal cream of mixing yogurt, honey and clotrimazole on symptoms of vaginal candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Honey; Humans; Treatment | 2015 |
The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clot | 2016 |
The Effects of Ozonated Olive Oil and Clotrimazole Cream for Treatment of Vulvovaginal Candidiasis.
Topics: Administration, Topical; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; | 2016 |
Effectiveness of Ageratina pichinchensis Extract in Patients with Vulvovaginal Candidiasis. A Randomized, Double-Blind, and Controlled Pilot Study.
Topics: Adult; Ageratina; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Doub | 2017 |
Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation.
Topics: Adhesiveness; Administration, Intravaginal; Animals; Antifungal Agents; Candidiasis, Vulvovaginal; C | 2009 |
Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial.
Topics: Adolescent; Adult; Antifungal Agents; Australia; Candida; Candidiasis, Vulvovaginal; Clotrimazole; F | 2011 |
Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth [ACTRN12610000607077].
Topics: Antifungal Agents; Australia; Candida; Candidiasis, Vulvovaginal; Clinical Protocols; Clotrimazole; | 2011 |
Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis.
Topics: Acute Disease; Administration, Intravaginal; Administration, Oral; Adult; Antifungal Agents; Candidi | 2011 |
Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis.
Topics: Acute Disease; Administration, Intravaginal; Anti-Infective Agents, Local; Antifungal Agents; Candid | 2003 |
A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses.
Topics: Administration, Intravaginal; Administration, Oral; Administration, Topical; Antifungal Agents; Cand | 2004 |
The importance of diagnostic work-up in the management of candidal vulvovaginitis. A prospective study.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Predicti | 2004 |
CVV in women with HIV.
Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Complement | 2005 |
["Mixed" and "miscellaneous" vulvovaginitis: diagnostics and therapy of vaginal administration of nystatin and nifuratel].
Topics: Administration, Intravaginal; Adult; Anti-Bacterial Agents; Antifungal Agents; Antitrichomonal Agent | 2005 |
The effect of treatment for vaginal yeast infection on the prevalence of bacterial vaginosis in early pregnancy.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Pregn | 2006 |
Fluconazole versus 3-day clotrimazole in the treatment of sporadic and recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Fl | 2006 |
A single-blind comparison of oral and intravaginal treatments in acute and recurrent vaginal candidosis in general practice.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; | 1984 |
Single blind comparison of ketoconazole 200 mg oral tablets and clotrimazole 100 mg vaginal tablets and 1% cream in treating acute vaginal candidosis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Candidiasis, Vulvovaginal; Clinica | 1984 |
Clotrimazole and econazole in the treatment of vaginal candidosis. A single-blind comparison.
Topics: Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Econazole; Female; Humans; Imidaz | 1983 |
A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use.
Topics: Adult; Aged; Candida; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Contracepti | 1983 |
Clinical evaluation of three-day treatment of vaginal mycosis with clotrimazole vaginal tablets.
Topics: Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles; Male; | 1983 |
[Candida vaginitis treated with a single dose of clotrimazole].
Topics: Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Femal | 1983 |
Single dose treatment of vaginal candidosis: comparison of clotrimazole and isoconazole.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Drug Administr | 1984 |
Treatment of vulvovaginal candidiasis with a 500-mg vaginal tablet of clotrimazole.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind M | 1984 |
Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double- | 1984 |
[Antimycotic effect of nifuratel: in vitro studies and clinical trial].
Topics: Candida; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Mycoses; | 1984 |
A three-day treatment regimen for vulvovaginal candidiasis.
Topics: Adolescent; Adult; Aged; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-B | 1982 |
One-dose therapy of Candida vaginitis. I. Results of an open multicentre trial.
Topics: Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles | 1982 |
Candida albicans vaginitis: the problem is diagnosis, the enigma is treatment.
Topics: Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Double-Blind Method; Female; Humans; Imid | 1982 |
Three-day therapy of vaginal candidiasis with clotrimazole vaginal tablets and econazole ovules: a multicenter comparative study.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Econazole; Fem | 1982 |
[Clotrimazole (Canesten) in the treatment of vulvar mycosis].
Topics: Candida; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Drug Resistance, Microbi | 1982 |
Vulvovaginal candidiasis: treatment and recurrence.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Child; Clotrimazole; Econazole; Fem | 1982 |
A concentrated therapeutic regimen for vulvovaginal candidiasis.
Topics: Aged; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Female | 1980 |
[Vulvar and vaginal mycoses in girls and their treatment].
Topics: Adolescent; Antifungal Agents; Candidiasis, Vulvovaginal; Child; Child, Preschool; Clinical Trials a | 1981 |
[Results of a single dose treatment with Canesten-vaginal tablets 500 mg in vaginal mycosis (author's transl)].
Topics: Adolescent; Adult; Aged; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; | 1981 |
Treatment of vaginal candidosis with a single 500-mg clotrimazole pessary.
Topics: Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Femal | 1982 |
Double-blind evaluation of miconazole tampons, compared with clotrimazole vaginal tablets, in vaginal candidiasis.
Topics: Adult; Candidiasis, Vulvovaginal; Clotrimazole; Double-Blind Method; Female; Humans; Imidazoles; Mic | 1981 |
Comparison of econazole and clotrimazole in the treatment of vulvovaginal candidiasis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Econazole; Female; Humans; Imidazoles; M | 1980 |
Three-day therapy of vaginal candidiasis with clotrimazole vaginal tablets and econazole ovules: a multicentre comparative study.
Topics: Adolescent; Adult; Aged; Candidiasis, Vulvovaginal; Clotrimazole; Econazole; Female; Humans; Imidazo | 1980 |
A comparison of a three-day and seven-day clotrimazole regimen for vulvovaginal candidiasis.
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Contraceptives, Oral, Hormonal; Drug Administration Schedul | 1981 |
Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Adolescent; Adult; Candidiasis, Vulvov | 1995 |
Econazole and clotrimazole in the treatment of vaginal candidiasis: a double blind comparative study.
Topics: Adolescent; Adult; Aged; Candidiasis, Vulvovaginal; Clotrimazole; Double-Blind Method; Econazole; Fe | 1994 |
A randomized, comparative study of a single oral dose of fluconazole versus a single topical dose of clotrimazole in the treatment of vaginal candidosis among general practitioners and gynaecologists.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Aged; Candidiasis, Vulvovagin | 1994 |
Initial management of recurrent vulvovaginal candidiasis with oral ketoconazole and topical clotrimazole.
Topics: Acute Disease; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Candidiasis, V | 1994 |
The value of prophylactic (monthly) clotrimazole versus empiric self-treatment in recurrent vaginal candidiasis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Cost-Benefit Analysis; Drug Costs; Femal | 1994 |
Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Double-Blind Method; Female; Huma | 1993 |
Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazol | 1993 |
Double-blind randomized dose-finding study in acute vulvovaginal candidosis. Comparison of flutrimazole site-release cream (1, 2 and 4%) with placebo site-release vaginal cream.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Double-Blind Me | 2000 |
Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment.
Topics: Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Femal | 1978 |
Prophylactic clotrimazole treatment to prevent mycoses contamination of the newborn.
Topics: Adult; Candidiasis; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Drug Evaluati | 1978 |
Clotrimazole for vulvovaginal candidiasis. Report of double-blind study.
Topics: Adult; Aged; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; | 1977 |
Seven-day clotrimazole therapy for vulvovaginal candidiasis.
Topics: Adolescent; Adult; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidaz | 1978 |
[Clotrimazole treatment of female genital infection by Candida albicans].
Topics: Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Drug Evaluation; Female; Humans; | 1978 |
Vulvovaginal candidiasis treated with clotrimazole cream in seven days compared with fourteen-day treatment with miconazole cream.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind M | 1978 |
Comparison of three-and six-day clotrimazole treatment for vaginal candidosis.
Topics: Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles; Pessa | 1978 |
Vulvovaginal candidiasis in pregnancy treated with clotrimazole.
Topics: Administration, Topical; Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clo | 1978 |
[Ultrastructure of Candida albicans in vitro and in vivo and its changes under exposure to canesten].
Topics: Candida albicans; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Drug Evaluation | 1979 |
Effect of simultaneous oral and vaginal treatment on the rate of cure and relapse in vaginal candidosis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Candidiasis, Vulvovaginal; Clinica | 1979 |
[Clinical experiences with clotrimazole in treating vaginal candidiasis].
Topics: Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Femal | 1979 |
A comparison between the effects of nystatin, clotrimazole and miconazole on vaginal candidiasis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Evaluation Studies as Topic; Female; Hum | 1979 |
[Experiences with canesten in treating mycotic infections of the vagina (author's transl)].
Topics: Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Drug Evaluation; Female; Humans; | 1976 |
[Experience with clotrimazole in the treatment of trichomoniasis and vaginal candiasis].
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Child; Clinical Trials as Topic; Clotrimazole; Drug Ev | 1975 |
Six-day clotrimazole therapy in vaginal candidosis.
Topics: Candida albicans; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; | 1975 |
Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Itraconazole; Ket | 1992 |
The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Itraconazole; | 1992 |
Comparison of topical fungicides in women suffering from vulvovaginitis.
Topics: Administration, Intravaginal; Administration, Oral; Candidiasis, Vulvovaginal; Clotrimazole; Female; | 1991 |
Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Aged; Candidiasis, Vulvovagin | 1991 |
Comparison of vaginal flora after treatment with a clotrimazole 500 mg vaginal pessary or a fluconazole 150 mg capsule for vaginal candidosis.
Topics: Administration, Oral; Bacteria; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Colony Count, Micr | 1991 |
[Terconazol in vaginal candidiasis. Comparative study].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Triazoles | 1990 |
[Terconazole in vaginal candidiasis. A comparative study].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Triazoles | 1990 |
Single-dose 500-mg clotrimazole vaginal tablets compared with placebo in the treatment of Candida vaginitis.
Topics: Administration, Intravaginal; Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Double-Bli | 1990 |
Single dose therapy of vaginal candidiasis: a comparative trial of fenticonazole vaginal ovules versus clotrimazole vaginal tablets.
Topics: Administration, Intravaginal; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotr | 1990 |
Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet.
Topics: Administration, Intravaginal; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Colony Count, Microbia | 1990 |
A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Report of an international multicentre trial.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovagi | 1989 |
Clotrimazole treatment of recurrent and chronic candida vulvovaginitis.
Topics: Adult; Candidiasis, Vulvovaginal; Chronic Disease; Clinical Trials as Topic; Clotrimazole; Double-Bl | 1989 |
Comparative clinical trial of fenticonazole ovule (600 mg) versus clotrimazole vaginal tablet (500 mg) in the treatment of symptomatic vaginal candidiasis.
Topics: Administration, Intravaginal; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotr | 1989 |
Intermittent local prophylaxis against recurrent vaginal candidosis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans | 1988 |
Prophylactic use of clotrimazole in recurrent vaginal candidosis.
Topics: Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles | 1988 |
[Vulvovaginal Candida mycoses--treatment with clotrimazole. Comparison of single-dose treatment with 6-day therapy].
Topics: Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Drug | 1988 |
[One-day trial therapy with 500 mg clotrimazole vaginal tablets and 150 mg econazole nitrate-depot ovules in vaginal mycoses: results of an open comparative study].
Topics: Administration, Intravaginal; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Delayed-Action Prepara | 1988 |
Three-day treatment with butoconazole vaginal suppositories for vulvovaginal candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Contrac | 1986 |
Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Drug Administr | 1986 |
Single-dose tioconazole compared with 3-day clotrimazole treatment in vulvovaginal candidiasis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clo | 1986 |
Therapy of candidal vaginitis: the effect of eliminating intestinal Candida. Nystatin Multicenter Study Group.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Ente | 1986 |
A comparative study of 3-day and 6-day clotrimazole therapy in patients with vaginal candidosis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind M | 1986 |
Effect of fenticonazole in vaginal candidiasis: a double-blind clinical trial versus clotrimazole.
Topics: Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Femal | 1986 |
Clinical toxicology of one-day administration of 500 mg of clotrimazole.
Topics: Administration, Intravaginal; Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic | 1987 |
One-day treatment of vulvovaginal candidiasis with a 500-mg clotrimazole vaginal tablet compared with a three-day regimen of two 100-mg vaginal tablets daily.
Topics: Adult; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Humans; Imidaz | 1986 |
[Single-dose therapy of vaginal mycoses with a 10% clotrimazole vaginal cream].
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Humans; Imidazoles; R | 1986 |
Comparative double-blind evaluation of the efficacy and tolerability of terconazole 240-mg suppository (1 day) and 80-mg suppositories (3 days) versus clotrimazole 200-mg (3 days) in pregnant patients with vulvovaginal candidosis.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double- | 1985 |
One-day treatment of vaginal candidosis: comparison of terconazole 240-mg suppository with clotrimazole 500-mg vaginal tablet.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; | 1985 |
Efficacy and tolerability of single-dose versus six-day treatment of candidal vulvovaginitis with vaginal tablets of clotrimazole.
Topics: Administration, Topical; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; | 1985 |
Is more than one application of an antifungal necessary in the treatment of acute vaginal candidiasis?
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole | 1985 |
Efficacy of single- versus multiple-dose clotrimazole therapy in the management of vulvovaginal candidiasis.
Topics: Adult; Aged; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; | 1985 |
Therapeutic results obtained in vaginal mycoses after single-dose treatment with 500 mg clotrimazole vaginal tablets.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind M | 1985 |
Treatment of vaginal candidosis using clotrimazole vaginal cream: single dose versus 3-day therapy.
Topics: Administration, Topical; Adolescent; Adult; Balanitis; Candidiasis; Candidiasis, Vulvovaginal; Clini | 1985 |
A comparative trial of six day therapy with clotrimazole and nystatin in pregnant patients with vaginal candidiasis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Nystatin; Pr | 1974 |
A double-blind comparison of clotrimazole and nystatin vaginal tablets in candida vaginitis.
Topics: Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles; Nysta | 1974 |
Treatment of candidiasis and trichomoniasis of the female genital tract.
Topics: Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles; Trich | 1974 |
The treatment of trichomonas and candida vaginitis with clotrimazole vaginal tablets.
Topics: Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles; Trich | 1974 |
The incidence of vaginal candida and trichomonas infections and treatment of trichomonas vaginitis with clotrimazole.
Topics: Adult; Aged; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imid | 1974 |
Vaginal candidiasis in pregnancy--a trial of clotrimazole.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans | 1974 |
An open trial of local therapy with clotrimazole for vaginal candidiasis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans | 1974 |
Clotrimazole in the treatment of acute and "resistant' vaginal candidiasis.
Topics: Amphotericin B; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Drug Resistance, | 1974 |
A preliminary report on a trial of clotrimazole against vaginal candidiasis in venereology.
Topics: Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles | 1974 |
A trial of clotrimazole and nystatin in vaginal candidiasis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans | 1974 |
Treatment of vaginal candidiasis with clotrimazole.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans | 1974 |
108 other studies available for clotrimazole and Candidiasis, Genital
Article | Year |
---|---|
1-[4-(4-Chlorophenyl)-2-(2,6-dichlorophenylthio)-n-butyl]-1H-imidazole nitrate, a new potent antifungal agent.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Chlorobenzenes; Female; Imi | 1978 |
Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Dermatomycoses; Female; Guinea Pigs; Rats; Tr | 1983 |
Evaluation of the anticandidal activity of clotrimazole using Lactobacillus caseie ghosts as biological drug carrier.
Topics: Antifungal Agents; Biological Products; Candidiasis, Vulvovaginal; Clotrimazole; DNA; Drug Carriers; | 2022 |
Improved treatment of vulvovaginal candidiasis with Clotrimazole plus probiotic Lacidophilin Vaginal Capsules: A prospective, real-world study.
Topics: Bacteria; Candidiasis, Vulvovaginal; Capsules; Clotrimazole; Female; Humans; Probiotics; Prospective | 2023 |
Chitosan-based sponges containing clotrimazole for the topical management of vulvovaginal candidiasis.
Topics: Administration, Topical; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Chitosan; C | 2023 |
The application of nanomaterial science in the formulation a novel antibiotic: Assessment of the antifungal properties of mucoadhesive clotrimazole loaded nanofiber versus vaginal films.
Topics: Administration, Intravaginal; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; C | 2020 |
3D printed clotrimazole intravaginal ring for the treatment of recurrent vaginal candidiasis.
Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Drug Liber | 2021 |
Clotrimazole-loaded N-(2-hydroxy)-propyl-3-trimethylammonium, O-palmitoyl chitosan nanoparticles for topical treatment of vulvovaginal candidiasis.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Chitosan; Clotrimazole; Female; Humans; Nanop | 2021 |
Vaginal antimycotics and the risk for spontaneous abortions.
Topics: Abortion, Spontaneous; Administration, Intravaginal; Adult; Antifungal Agents; Candidiasis, Vulvovag | 2018 |
Clotrimazole dampens vaginal inflammation and neutrophil infiltration in response to Candida albicans infection.
Topics: Candida albicans; Candidiasis, Vulvovaginal; Cell Line; Clotrimazole; Female; Humans; Neutrophil Inf | 2013 |
Bioadhesive vaginal tablets containing spray dried microspheres loaded with clotrimazole for treatment of vaginal candidiasis.
Topics: Acrylic Resins; Administration, Intravaginal; Animals; Antifungal Agents; Candidiasis, Vulvovaginal; | 2013 |
[Topical treatment of vaginal infections by the association of metronidazole-clotrimazole].
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Metronidazole; | 2013 |
Formulation and in vitro evaluation of coconut oil-core cationic nanocapsules intended for vaginal delivery of clotrimazole.
Topics: Administration, Intravaginal; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vu | 2014 |
Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
Topics: Administration, Intravaginal; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotr | 2014 |
Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance, Fungal; | 2015 |
Antifungal activity of clotrimazole against Candida albicans depends on carbon sources, growth phase and morphology.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Cell Proliferation; Clotrimazole; Dr | 2015 |
[Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance, Fungal; Female | 2016 |
Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; China; Clotrimazole; Drug Resistance, Fungal; | 2016 |
Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504).
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Lacto | 2016 |
Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis.
Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvov | 2017 |
Protective activity of geranium oil and its component, geraniol, in combination with vaginal washing against vaginal candidiasis in mice.
Topics: Acyclic Monoterpenes; Administration, Intravaginal; Animals; Antifungal Agents; Candida albicans; Ca | 2008 |
FPIN’s clinical inquiries: treatment of recurrent vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Cl | 2011 |
Artemisia princeps Pamp. Essential oil and its constituents eucalyptol and α-terpineol ameliorate bacterial vaginosis and vulvovaginal candidiasis in mice by inhibiting bacterial growth and NF-κB activation.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Artemisia; Candida albi | 2011 |
Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis, V | 2002 |
[Is vaginal fungi hazardous for the pregnancy?].
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Infant, Newborn; Pregnan | 2004 |
Chronic vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fl | 2004 |
Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Databases as Topic; D | 2004 |
The use of data set of the Hungarian case-control surveillance of congenital abnormalities for evaluation of birth outcomes beyond birth defects.
Topics: Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Conge | 2007 |
[Dose-related effects of the polyene antifungal drug natamycin in a galenic form of newly developed suppository in vaginal yeast infections].
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Dose-Response Relationship, Drug; Female | 1984 |
Three-day clotrimazole therapy for vulvo-vaginal mycosis.
Topics: Adult; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Evaluation; Female; Humans; Imidazoles | 1983 |
Treatment of vaginal candidiasis in pregnancy with a single clotrimazole 500 mg vaginal pessary.
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Pessaries; Pregnancy; Pregnancy | 1984 |
[Treatment results after a single local application of 500 mg of clotrimazole in vaginal mycoses during pregnancy].
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Hu | 1984 |
Genital candidiasis.
Topics: Candidiasis; Candidiasis, Vulvovaginal; Clotrimazole; Female; Genital Diseases, Male; Gonorrhea; Hum | 1983 |
[Canesten (clotrimazole) in the treatment of vulvovaginal moniliasis].
Topics: Adult; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Middle | 1980 |
[Comparison of the effectiveness of nystatin and kanesten in the treatment of vulvovaginal candidiasis].
Topics: Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Drug Evaluation; Femal | 1981 |
[Vaginal candidiasis treated with tioconazol and chlotrimazol].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Middl | 1982 |
[Clotrimazole in a new formula].
Topics: Adolescent; Adult; Aged; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Middle | 1982 |
[Treatment of Candida vulvovaginitis with clotrimazole in a 2% vaginal cream for 3 days].
Topics: Adult; Candidiasis, Vulvovaginal; Clotrimazole; Drug Evaluation; Female; Humans; Imidazoles; Male; M | 1982 |
Vaginal secretion levels after 6 days, 3 days and 1 day of treatment with 100, 200 and 500 mg vaginal tablets of clotrimazole and their therapeutic efficacy.
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Dose-Response Relationship, Drug; Drug Combinations; Female | 1982 |
Patient compliance and the short-term treatment regimen.
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Humans; Miconazole; P | 1982 |
Comparison of miconazole-coated tampons with clotrimazole vaginal tablets in the treatment of vaginal candidosis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Miconazole; | 1981 |
[Therapeutic effectiveness of Canesten in treating urogenital candidiasis].
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Drug Evaluation; Female; Humans; Imidazoles; Time Factors; | 1980 |
[Resistance problems in treatment of vaginal mycoses? (author's transl)].
Topics: Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance, Microbial; Female; Humans; Nystat | 1980 |
The rectal carriage of yeast in patients with vaginal candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Candida albicans; Candidiasis | 1994 |
Physicians' perceptions of the impact of the reclassification of vaginal antifungal agents.
Topics: Antifungal Agents; Attitude of Health Personnel; Candidiasis, Vulvovaginal; Clotrimazole; Family Pra | 1994 |
Efficacy of butoconazole nitrate in the treatment of vulvo-vaginal candidiasis compared with clotrimazol and isoconasol.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Contraception; Female; Humans; Im | 1993 |
[The possibilities for treating vaginal candidiasis with a single dose of clotrimazole 500 mg].
Topics: Administration, Intravaginal; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Drug Evaluation; Femal | 1995 |
Anticandidal activity of Santolina chamaecyparissus volatile oil.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Dermatomycose | 1997 |
[The treatment of vaginal candidiasis during pregnancy with a single dose of clotrimazole].
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Pregn | 1996 |
Fetal Candida sepsis at midgestation: a case report.
Topics: Administration, Intravaginal; Adult; Anti-Infective Agents, Local; Autopsy; Candida albicans; Candid | 1998 |
Efficacy of syringomycin E in a murine model of vaginal candidiasis.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Chromatography, High Pressure Liquid; Clotrim | 1998 |
A lower rate of preterm birth after clotrimazole therapy during pregnancy.
Topics: Adult; Antifungal Agents; Birth Weight; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Hun | 1999 |
No teratogenic effect after clotrimazole therapy during pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Case-Control Studi | 1999 |
[Candida albicans vaginitis in pregnant women--what treatment is recommended?].
Topics: Anti-Infective Agents, Local; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Hu | 2000 |
[Diagnosis and treatment of chronic vaginal candidiasis].
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Clotrimazole; Female; Humans; Natamyc | 1999 |
Involvement of aspirin-sensitive oxylipins in vulvovaginal candidiasis.
Topics: Antifungal Agents; Arachidonic Acids; Aspirin; Candida albicans; Candidiasis, Vulvovaginal; Clotrima | 2001 |
Fungal infection overview.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Candidiasis | 1995 |
An investigation into the pathogenesis of vulvo-vaginal candidosis.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance | 2001 |
[Vulvovaginal candidiasis in childhood--diagnostic and therapeutic results].
Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Bulgaria; Candidiasis, Vulvovaginal; Child; Ch | 2001 |
Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis.
Topics: Adhesives; Administration, Intravaginal; Animals; Antifungal Agents; Candida albicans; Candidiasis, | 2002 |
Evaluation of vaginal antifungal formulations in vivo.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Disease Model | 1979 |
[The reaction of the physiological vaginal flora to topical antimycotics (author's transl)].
Topics: Antifungal Agents; Bacteria; Candida; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Fem | 1979 |
Current approaches to the diagnosis, treatment, and reporting of trichomoniasis and candidosis.
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Male; Medical Records; Metronidazole; Nysta | 1979 |
[Therapeutic results of treatment of vaginal candidiasis with Canesten].
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imida | 1979 |
Candida infections.
Topics: Amphotericin B; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; C | 1979 |
[Topical treatment of genital mycoses. Clinical study with clotrimazole].
Topics: Administration, Topical; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Genital Diseases, F | 1979 |
The frequency of Candida infections in pregnancy and their treatment with clotrimazole.
Topics: Abortion, Spontaneous; Adolescent; Adult; Candidiasis; Candidiasis, Vulvovaginal; Child; Clotrimazol | 1977 |
The antifungal imidazoles: clotrimazole and miconazole.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Dermatomycoses; Female; Humans; Imidazol | 1978 |
[Treatment of Candida vulvovaginitis with clotrimazol for 3 days].
Topics: Adult; Aged; Candidiasis, Vulvovaginal; Clotrimazole; Drug Evaluation; Female; Humans; Imidazoles; M | 1978 |
Treatment of fungal vulvovaginitis with Canesten.
Topics: Adolescent; Adult; Aged; Candidiasis, Vulvovaginal; Child; Clotrimazole; Female; Humans; Imidazoles; | 1978 |
Clotrimazole in treatment of dermatomycoses and vaginitis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Candidiasis, Vulvovaginal; Clotrimazole; Dermatomy | 1977 |
Topical pharmacology of imidazole antifungals.
Topics: Administration, Topical; Antifungal Agents; Benzimidazoles; Candidiasis, Vulvovaginal; Clotrimazole; | 1976 |
Gyne-lotrimin for vaginal infections.
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Pregnancy; Pregnancy Complicati | 1976 |
Genital candidiasis: topical management with clotrimazole.
Topics: Administration, Oral; Administration, Topical; Candidiasis, Cutaneous; Candidiasis, Vulvovaginal; Cl | 1976 |
[Fungal infections after renal transplantation (author's transl)].
Topics: Adult; Amphotericin B; Candidiasis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Cholestasis | 1975 |
[Clinical evaluation of clotrimazol in vulvovaginal moniliasis].
Topics: Adult; Candidiasis, Vulvovaginal; Clotrimazole; Drug Evaluation; Female; Humans; Imidazoles; Middle | 1975 |
[Preliminary results of the use of an antimycotic drug, clotrimazole (bis-phenyl-(2-chlorophenyl)-1-imidazoly-methane: BAY b 5097) in local administration for therapy of vaginitis caused by Candida albicans and by Trichomonas vaginalis].
Topics: Antifungal Agents; Antitrichomonal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; | 1975 |
[A case of generalized Candida albicans infection].
Topics: Adolescent; Antifungal Agents; Candidiasis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Cefazolin; | 1975 |
Letter: Vaginal candidosis.
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Nystatin; Patient Compliance | 1976 |
In vitro and in vivo studies with flutrimazole, a new imidazole derivative with antifungal activity.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fungi; Guinea Pigs; Imi | 1992 |
Clotrimazole for vaginal yeast infections.
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans | 1992 |
A true cure for vaginal candidiasis?
Topics: Administration, Intravaginal; Administration, Oral; Candidiasis, Vulvovaginal; Clotrimazole; Female; | 1992 |
In vitro and in vivo candicidal activities of 2-(p-n-hexylphenylamino)-1,3-thiazoline.
Topics: Administration, Topical; Animals; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Colony | 1991 |
The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis, Vulvovagi | 1991 |
From the Food and Drug Administration.
Topics: Aged; American Dental Association; Candidiasis, Vulvovaginal; Clotrimazole; Drug Labeling; Female; G | 1991 |
Econazole nitrate (150 mg) single dose vaginal pessary compared with clotrimazole (10%) single dose vaginal cream to treat women with vaginal candidiasis.
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Drug Evaluation; Econazole; Female; Humans; Imidazoles; Pes | 1989 |
[Butoconazole nitrate in vulvovaginal candidiasis. A comparative study with clotrimazole].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Drug Evaluation; Drug Tolerance; | 1988 |
Three-day treatment of vulvovaginal candidiasis.
Topics: Adult; Candidiasis, Vulvovaginal; Clotrimazole; Drug Evaluation; Female; Humans; Imidazoles; Miconaz | 1988 |
Activity of terbinafine in experimental fungal infections of laboratory animals.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Dermatomycoses; Female; Guinea | 1987 |
Comparative study of local and oral treatment of vaginal candidiasis (Canesten-Nizoral).
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Candidiasis, Vulvovaginal; Cl | 1987 |
Treatment of vaginal discharge caused by blastomycetes with nizoral tablet.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Ketoconazole; Leukorrhea | 1986 |
[Treatment of vulvovaginal candidiasis with a single dose of Canesten (500 mg) in young girls 10 years of age and older, with an intact hymen].
Topics: Administration, Intravaginal; Adolescent; Adult; Candidiasis, Vulvovaginal; Child; Clotrimazole; Fem | 1987 |
The treatment of inveterate vulvo-vaginal candidosis.
Topics: Adrenal Cortex Hormones; Boric Acids; Candidiasis, Vulvovaginal; Chronic Disease; Clotrimazole; Cont | 1986 |
Single dose clotrimazole vaginal cream (10%) in the treatment of vaginal candidiasis.
Topics: Administration, Intravaginal; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidaz | 1987 |
One-day management of vulvovaginal candidiasis.
Topics: Adolescent; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Humans; I | 1987 |
Attributes of microorganisms that contribute to recurrence and intractability of vaginal mycosis.
Topics: Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance, Microbial; Female; Humans; Recurr | 1986 |
[Mixed infections of the urogenital tract with Trichomonas vaginalis and yeast-like fungi in humans with reference to treatment].
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrim | 1986 |
Treatment of vaginal candidiasis in pregnant women.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Micon | 1986 |
Clotrimazole pessary compared with cream in treating women with vaginal candidosis.
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Pessaries; Vaginal Creams, Foam | 1986 |
Terconazole 0.8% vaginal cream (5 days) versus clotrimazole 1% (6 days): efficacy and tolerability in an open study.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Triaz | 1985 |
Comparative open evaluation of efficacy and tolerability of terconazole 0.8% cream in a 5-day regimen versus clotrimazole 100-mg tablets in a 6-day regimen.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imida | 1985 |
Demonstration of effectiveness and tolerability of terconazole 80-mg vaginal suppositories (3 days) versus terconazole 240-mg vaginal suppositories (1 day) versus clotrimazole 200-mg vaginal tablets (3 days) in non-pregnant women with vulvovaginal candido
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Suppositorie | 1985 |
Classification and pathogenesis of vulvovaginal candidiasis.
Topics: Anti-Bacterial Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Ketoconazole; Risk; | 1985 |
Treatment of recurrent vaginal candidiasis.
Topics: Administration, Oral; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Male; Pat | 1985 |
Repeated candidiasis: reinfection or recrudescence? A review.
Topics: Anti-Bacterial Agents; Candidiasis, Vulvovaginal; Clothing; Clotrimazole; Contraceptives, Oral; Diab | 1985 |
[Value of clotrimazole (BAY B 5097 or Canesten) as an antimycotic, antiprotozoal and antibacterial agent in vulvo-vaginal inflammations].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Candidiasis, Vulvovaginal; Clotrimazole; Female; Huma | 1974 |
Local and systemic treatment of vaginal candidiasis.
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Nausea; Pregnancy | 1974 |
Mycological studies in the use of clotrimazole in bronchopulmonary aspergillosis and neonatal and vaginal candidiasis.
Topics: Aspergillosis; Candidiasis; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Inf | 1974 |